The key market opportunities in next-generation oncology devices include enhancing precision diagnostics and targeted ...

Esther Ugwueke is a biomedical expert and PhD student at the University of Nebraska Medical Center, United States, where she studies and researches lung cancer using bioinformatics, artificial ...

Market opportunities in pet oncology include leveraging breakthroughs in immunotherapy and precision medicine. Tailored treatment plans, enhanced by bioinformatics and genomic profiling, foster ...

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease.

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug suppresses tumour activity and ...

Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women – but until now, they were underrepresented in genomic studies aimed at ...

A South Korean research team has developed the first-ever "molecular reversion switch" technology that returns cancer cells ...

Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause of mortality worldwide, highlighting the urgent need for continued research to identify ...

"India is not just a cost center—it’s becoming a core innovation engine for us," said Ankur Dhingra, Chief Financial Officer ...

Researchers have discovered that statins, drugs typically used for high cholesterol, could potentially slow the growth of colorectal cancer cells.